Skip to Content

Doxazosin Pregnancy and Breastfeeding Warnings

Doxazosin is also known as: Cardura, Cardura XL, Carduran, Cascor, Doxadura

Doxazosin Pregnancy Warnings

Doxazosin has been assigned to pregnancy category C by the FDA. Animal studies have shown that the drug crosses the placenta and that there is decreased fetal survival when rabbits were given 300 times the maximum recommended human dose. Animal studies have failed to reveal evidence of fetal harm after doses 154 and 75 times the maximum recommended human dose were given to pregnant rabbits and rats, respectively. Because animal reproductive studies are not always predictive of human response, doxazosin should be used in pregnancy when there are no alternatives and benefit outweighs risk.

See references

Doxazosin Breastfeeding Warnings

There are no data on the excretion of doxazosin into human milk. Because many drugs are excreted in human milk, caution should be exercised when doxazosin is administered to a nursing mother.

See references

References for pregnancy information

  1. "Product Information. Cardura (doxazosin)." Pfizer US Pharmaceuticals, New York, NY.

References for breastfeeding information

  1. "Product Information. Cardura (doxazosin)." Pfizer US Pharmaceuticals, New York, NY.

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.